⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12641478 | 0.92 | — | — | |
| SCHEMBL29240120 | 0.90 | ALDH1A1 (0.55) | — | |
| SCHEMBL1962359 | 0.83 | — | — | |
| SCHEMBL28219205 | 0.83 | ALDH1A1 (0.62) | — | |
| SCHEMBL218953 | 0.83 | KDM4E (0.60) | — | |
| SCHEMBL49856 | 0.83 | ALDH1A1 (0.62) | — | |
| Methane SCHEMBL9381644 | 0.81 | — | — | |
| SCHEMBL4187314 | 0.80 | KDM4E (0.65) | — | |
| SCHEMBL4186692 | 0.80 | ALDH1A1 (0.67) | — | |
| Ammonia Solution, Strong SCHEMBL15129241 | 0.80 | ALDH1A1 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3095467-B1 | ANTIBODY-ENZYME CONJUGATE | VENTANA MED SYST INC (US) | 2020-05-06 | — | — | EP | claimed |
| EP-2963011-B1 | MOLECULAR CONJUGATE | VENTANA MED SYST INC (US) | 2018-05-09 | — | — | EP | claimed |
| EP-3095467-A1 | MOLECULAR CONJUGATE | Ventana Medical Systems, Inc. (US) | 2016-11-23 | — | — | EP | claimed |
| US-20160195540-A1 | Molecular Conjugate | VENTANA MED SYST INC (US) | 2016-07-07 | — | — | US | claimed |
| US-9310373-B2 | Molecular conjugate | VENTANA MEDICAL SYSTEMS, INC. (US) | 2016-04-12 | — | — | US | claimed |
| EP-2963011-A1 | MOLECULAR CONJUGATE | Ventana Medical Systems, Inc. (US) | 2016-01-06 | — | — | EP | claimed |
| US-20140205995-A1 | MOLECULAR CONJUGATE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-07-24 | — | — | US | claimed |
| US-20260109728-A1 | IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE | TALLAC THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12351598-B2 | Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use | Tallac Therapeutics, Inc. (US) | 2025-07-08 | — | — | US | disclosed |
| US-12280021-B2 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2025-04-22 | — | — | US | disclosed |
| US-20230372267-A1 | AFFINITY MEDICANT CONJUGATE | Califia Pharma Inc. (US) | 2023-11-23 | — | — | US | disclosed |
| US-20220056069-A1 | IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE | HORIZON TECHNOLOGY FINANCE CORPORATION | 2022-02-24 | — | — | US | disclosed |
| US-11241398-B2 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2022-02-08 | — | — | US | disclosed |
| WO-2008153744-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| EP-1951316-A2 | MOLECULAR CONJUGATE | Ventana Medical Systems, Inc. (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007062177-A2 | MOLECULAR CONJUGATE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007062177-A2 | MOLECULAR CONJUGATE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20070117153-A1 | Molecular conjugate | VENTANA MEDICAL SYSTEMS, INC. | 2007-05-24 | — | — | US | disclosed |
| US-20070117153-A1 | Molecular conjugate | VENTANA MEDICAL SYSTEMS, INC. | 2007-05-24 | — | — | US | disclosed |
| US-20070117153-A1 | Molecular conjugate | VENTANA MEDICAL SYSTEMS, INC. | 2007-05-24 | — | — | US | disclosed |